Search results

Selected filters:

News
Life Sciences

Article type

Topic

Sector

Regions

Year

147 results found for your search

Sort options
22 January 2019

Bridgestone's TomTom acquisition shows that data is the new gold rush

The $1 billion deal emphasises that for IP professionals a detailed understanding of data-related issues is set to become essential

21 January 2019

It's time to prepare for the IP monetisation revolution

The rise of disruptive new technology means that everything you thought you knew about making money from IP is set to change

18 January 2019

The clock is ticking as US government shutdown threatens to cause major pharma patent disruption

Services at the FDA could “grind to a halt” in a matter weeks if the budget deadlock between President Trump and Democrats continues. Major disruption at the USPTO and in the courts may also be on the cards.

16 January 2019

New collaboration between leading IP brands set to boost global patent transactions

IAM Market teams up with Richardson Oliver Insights to deliver new tranche of assets to its IP buying, selling, licensing and tech transfer platform being offered by top brokers

16 January 2019

Five things you must know about CRISPR

An insider’s guide to how it has revolutionised the life sciences patent landscape - and will continue to do so

15 January 2019

Indian IP jurisprudence is the real winner in the Monsanto cotton technology case

Supreme Court decision does not bring any clarity to the technical issues at stake, but it does establish clear rules for how judges should handle complex patent suits

21 December 2018

Life sciences round-up - UK Supreme Court rules in landmark case, patent linkage shelved in China, big CAFC decision and much more

A summary of the major IP news from the biotechnology, pharmaceutical and medical technology sectors in November and the first-half of December

12 December 2018

Supreme Court of India set to rule in crucial plant innovation dispute

The decision in Monsanto’s appeal against the revocation of a key patent right could have profound implications on the ability to protect agro-biotech inventions in India

04 December 2018

All the action from the final day of IPBC Asia 2018

This year's event in Shanghai has now come to an end. It's been a great couple of days, including the IP Asia Elite Gala Dinner and Awards held last night

03 December 2018

IPBC Asia Day One report - all the highlights from another sell-out event

How Chinese courts will rule the patent world; Qualcomm's 5G licensing spree; don't jail trolls, says former supreme court judge; patent sales are on the up; plus a whole lot more from a wet, but spectacular, Shanghai Pudong

02 December 2018

Oppo’s big Nokia deal; pharma patents under pressure; Silicon Valley woe; patent market data revealed; plus much more

Your essential Sunday reading: a summary of all the stories posted on the IAM platform in the past week - as well as links to each one

26 November 2018

Pharma patent owners in the US are under pressure like they have never been before

Life sciences IP is on the front line as American consumers, legislators and the Trump administration kick back against the high cost of medicines. Reform campaigners say they have never been more confident of change.

25 November 2018

Patent sales on the rise; Microsoft’s deal with Chinese drone company; a deep dive into Oppo’s portfolio; IP insurance goes mainstream; and much more

Your essential Sunday reading: a summary of all the stories posted on the IAM platform in the past week - as well as links to each one

19 November 2018

Dosage patents come under scrutiny at UK Supreme Court

Justices today considering a much-anticipated case whose outcome could make it harder for pharma companies to obtain such protection in the future

15 November 2018

Congress needs role in key patent reform debates, says senior GOP legislator

Tipped to be the ranking Republican on the House Judiciary Committee, Doug Collins looks set to emerge as one of most powerful IP policy voices on Capitol Hill